Johnson & Johnson (NYSE:JNJ)

CAPS Rating: 5 out of 5

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.

Recs

0
Player Avatar Danpines (44.20) Submitted: 1/4/2012 5:54:58 PM : Underperform Start Price: $64.30 JNJ Score: +6.02

This company has product recalls every month. Their market share is going south. Well run companies do not have recall problems. This is not a well run company and the market will price that in the share price over the next 24 to 48 months.

Featured Broker Partners


Advertisement